HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II.

Abstract
Recently mitochondria in cancer cells have emerged as the Achilles heel for tumour destruction. Anti-cancer agents specifically targeting cancer cell mitochondria are referred to as 'mitocans'. These compounds act by destabilising these organelles, unleashing their apoptogenic potential, resulting in the efficient death of malignant cells and suppression of tumour growth. Importantly, at least some mitocans are selective for cancer cells, and these are represented by the group of redox-silent vitamin E analogues, epitomised by alpha-tocopheryl succinate (alpha-TOS). This compound has proven itself in pre-clinical models to be an efficient anti-cancer agent, targeting complex II of the respiratory chain to displace ubiquinone binding. We propose that disrupting the electron flow of mitochondrial complex II results in generation of superoxide, triggering mitochondrial destabilisation and initiation of apoptotic pathways. Moreover, alpha-TOS is selective for cancer cells with their reduced anti-oxidant defenses and lower esterase activity than the normal (non-malignant) counterparts. In this mini-review we discuss the emerging significance of mitocans, as exemplified by alpha-TOS.
AuthorsJiri Neuzil, Jeffrey C Dyason, Ruth Freeman, Lan-Feng Dong, Lubomir Prochazka, Xiu-Fang Wang, Immo Scheffler, Stephen J Ralph
JournalJournal of bioenergetics and biomembranes (J Bioenerg Biomembr) Vol. 39 Issue 1 Pg. 65-72 (Feb 2007) ISSN: 0145-479X [Print] United States
PMID17294131 (Publication Type: Journal Article, Review)
Chemical References
  • Antineoplastic Agents
  • Reactive Oxygen Species
  • Superoxides
  • Vitamin E
  • Electron Transport Complex II
Topics
  • Animals
  • Antineoplastic Agents (pharmacology, therapeutic use)
  • Electron Transport Complex II (drug effects, metabolism)
  • Humans
  • Mitochondria (drug effects, physiology)
  • Models, Molecular
  • Neoplasms (drug therapy)
  • Reactive Oxygen Species (metabolism)
  • Superoxides (metabolism)
  • Vitamin E (analogs & derivatives, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: